Novo Nordisk presents key findings from semaglutide trials at ADA scientific sessions 2024

22

Jun , 2024

Novo Nordisk presents key findings from semaglutide trials at ADA scientific sessions 2024

Novo Nordisk today announced the presentation of 34 abstracts highlighting the breadth of its portfolio at the upcoming 84th Scientific Sessions of the American Diabetes Association (ADA). The conference will be held in-person and virtually from 21–24 June 2024 in Orlando, US. Additional data from three landmark trials with semaglutide will also be presented in dedicated […]

20

Jan , 2024

Tag: Hypoglycemia

New oral insulin delivered via nano-carriers could soon replace injections

There are approximately 425 million people worldwide with diabetes. Approximately 75 million of these inject themselves with insulin daily. Now they may soon have a new alternative to syringes or insulin pumps. Scientists have found a new way to supply the body with smart insulin. The new insulin can be eaten by taking a capsule […]

7

Oct , 2023

Tag: Hypoglycemia

A telehealth model to support remote diabetes self-care

In a recent study published in JAMA Network Open, researchers develop and test the effectiveness of a Virtual Diabetes Specialty Clinic (VDiSC), a virtual model facilitating comprehensive diabetes care remotely. VDiSC integrates and supports continuous glucose monitoring (CGM) for self-management of diabetes. This platform also provides behavioral health support for diabetes-related complications and helps evaluate decision-support […]